BTC Health Ltd

AU:BTC Australia Biotechnology
Market Cap
$13.06 Million
AU$21.09 Million AUD
Market Cap Rank
#49212 Global
#1581 in Australia
Share Price
AU$0.06
Change (1 day)
+3.51%
52-Week Range
AU$0.05 - AU$0.07
All Time High
AU$0.24
About

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cel… Read more

BTC Health Ltd (BTC) - Net Assets

Latest net assets as of December 2025: AU$11.06 Million AUD

Based on the latest financial reports, BTC Health Ltd (BTC) has net assets worth AU$11.06 Million AUD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$11.31 Million) and total liabilities (AU$248.95K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$11.06 Million
% of Total Assets 97.8%
Annual Growth Rate -5.65%
5-Year Change -15.51%
10-Year Change 267.86%
Growth Volatility 72.62

BTC Health Ltd - Net Assets Trend (2000–2025)

This chart illustrates how BTC Health Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for BTC Health Ltd (2000–2025)

The table below shows the annual net assets of BTC Health Ltd from 2000 to 2025.

Year Net Assets Change
2025-06-30 AU$9.16 Million +85.17%
2024-06-30 AU$4.94 Million +77.88%
2023-06-30 AU$2.78 Million -78.39%
2022-06-30 AU$12.86 Million +18.68%
2021-06-30 AU$10.84 Million -3.49%
2020-06-30 AU$11.23 Million -0.99%
2019-06-30 AU$11.34 Million +281.48%
2018-06-30 AU$2.97 Million -25.28%
2017-06-30 AU$3.98 Million +59.85%
2016-06-30 AU$2.49 Million +140.26%
2015-06-30 AU$1.04 Million -18.16%
2014-06-30 AU$1.27 Million -59.87%
2013-06-30 AU$3.15 Million -31.28%
2012-06-30 AU$4.59 Million -43.15%
2011-06-30 AU$8.08 Million -49.77%
2010-06-30 AU$16.08 Million -31.21%
2009-06-30 AU$23.37 Million -16.70%
2008-06-30 AU$28.06 Million -24.97%
2007-06-30 AU$37.40 Million -18.85%
2006-06-30 AU$46.09 Million +9.10%
2005-06-30 AU$42.24 Million -9.73%
2004-06-30 AU$46.80 Million +19.75%
2003-06-30 AU$39.08 Million -0.01%
2002-06-30 AU$39.08 Million +0.22%
2001-06-30 AU$38.99 Million -0.45%
2000-06-30 AU$39.17 Million --

Equity Component Analysis

This analysis shows how different components contribute to BTC Health Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 4813585700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$56.61 Million 618.28%
Other Comprehensive Income AU$680.09K 7.43%
Total Equity AU$9.16 Million 100.00%

BTC Health Ltd Competitors by Market Cap

The table below lists competitors of BTC Health Ltd ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BTC Health Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 4,944,859 to 9,156,465, a change of 4,211,606 (85.2%).
  • Net income of 3,981,298 contributed positively to equity growth.
  • Share repurchases of 58,800 reduced equity.
  • New share issuances of 58,800 increased equity.
  • Other comprehensive income increased equity by 171,508.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$3.98 Million +43.48%
Share Repurchases AU$58.80K -0.64%
Share Issuances AU$58.80K +0.64%
Other Comprehensive Income AU$171.51K +1.87%
Other Changes AU$58.80K +0.64%
Total Change AU$- 85.17%

Book Value vs Market Value Analysis

This analysis compares BTC Health Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.09x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.06x to 2.09x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2000-06-30 AU$0.98 AU$0.06 x
2001-06-30 AU$0.49 AU$0.06 x
2002-06-30 AU$0.49 AU$0.06 x
2003-06-30 AU$0.49 AU$0.06 x
2004-06-30 AU$0.51 AU$0.06 x
2005-06-30 AU$0.47 AU$0.06 x
2006-06-30 AU$0.52 AU$0.06 x
2007-06-30 AU$0.42 AU$0.06 x
2008-06-30 AU$0.33 AU$0.06 x
2009-06-30 AU$0.28 AU$0.06 x
2010-06-30 AU$0.21 AU$0.06 x
2011-06-30 AU$0.11 AU$0.06 x
2012-06-30 AU$0.06 AU$0.06 x
2013-06-30 AU$0.04 AU$0.06 x
2014-06-30 AU$0.02 AU$0.06 x
2015-06-30 AU$0.01 AU$0.06 x
2016-06-30 AU$0.03 AU$0.06 x
2017-06-30 AU$0.03 AU$0.06 x
2018-06-30 AU$0.02 AU$0.06 x
2019-06-30 AU$0.08 AU$0.06 x
2020-06-30 AU$0.05 AU$0.06 x
2021-06-30 AU$0.04 AU$0.06 x
2022-06-30 AU$0.05 AU$0.06 x
2023-06-30 AU$0.01 AU$0.06 x
2024-06-30 AU$0.02 AU$0.06 x
2025-06-30 AU$0.03 AU$0.06 x

Capital Efficiency Dashboard

This dashboard shows how efficiently BTC Health Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 43.48%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 39972.87%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 1.02x
  • Recent ROE (43.48%) is above the historical average (-32.22%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2001 1.65% 40.77% 0.04x 1.03x AU$-3.25 Million
2002 0.22% 215.00% 0.00x 1.01x AU$-3.82 Million
2003 -0.01% -0.39% 0.02x 1.01x AU$-3.91 Million
2004 -9.94% -486.21% 0.02x 1.03x AU$-9.33 Million
2005 -2.75% 0.00% 0.00x 1.00x AU$-5.39 Million
2006 -0.80% -1835.00% 0.00x 1.04x AU$-4.98 Million
2007 -2.03% -5838.46% 0.00x 1.01x AU$-4.50 Million
2008 -26.32% -369300.00% 0.00x 1.00x AU$-10.19 Million
2009 -18.54% -1430.03% 0.01x 1.00x AU$-6.67 Million
2010 -35.50% -9204.84% 0.00x 1.00x AU$-7.31 Million
2011 -43.28% 0.00% -0.03x 1.45x AU$-4.30 Million
2012 -40.51% 0.00% -0.01x 1.07x AU$-2.32 Million
2013 -15.91% -1061.06% 0.01x 1.00x AU$-817.49K
2014 -149.22% -12111.91% 0.01x 1.01x AU$-2.02 Million
2015 -48.94% -4467.13% 0.01x 1.02x AU$-610.62K
2016 -34.99% -1223.59% 0.03x 1.09x AU$-1.12 Million
2017 -12.98% -1812.38% 0.01x 1.17x AU$-914.41K
2018 -49.38% -3670.00% 0.01x 1.12x AU$-1.77 Million
2019 -4.81% -320.58% 0.01x 1.03x AU$-1.68 Million
2020 -2.52% -176.88% 0.01x 1.02x AU$-1.41 Million
2021 -3.62% -2042.73% 0.00x 1.20x AU$-1.48 Million
2022 -4.48% -606.29% 0.01x 1.01x AU$-1.86 Million
2023 -365.76% -76681.75% 0.00x 1.06x AU$-10.45 Million
2024 21.34% 6448.66% 0.00x 1.04x AU$560.51K
2025 43.48% 39972.87% 0.00x 1.02x AU$3.07 Million

Industry Comparison

This section compares BTC Health Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $34,090,589
  • Average return on equity (ROE) among peers: -67.07%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
BTC Health Ltd (BTC) AU$11.06 Million 1.65% 0.02x $364.22
Adalta Ltd (1AD) $2.03 Million -265.03% 1.74x $171.91K
Algorae Pharmaceuticals Ltd (1AI) $2.88 Million -33.65% 0.18x $9.99 Million
ACRUX Ltd (ACR) $17.49 Million -17.99% 0.05x $2.16 Million
Argenica Therapeutics Ltd (AGN) $13.95 Million -39.28% 0.17x $11.42 Million
Arovella Therapeutics Ltd (ALA) $11.23 Million -77.89% 0.18x $39.76 Million
Anatara Lifesciences Ltd (ANR) $5.92 Million -48.49% 0.08x $718.75K
Bio-Gene Technology Ltd (BGT) $4.25 Million -56.43% 0.18x $2.33 Million
Cambium Bio Ltd (CMB) $8.27 Million -79.86% 0.16x $8.11 Million
Clinuvel Pharmaceuticals Ltd (CUV) $240.81 Million 15.02% 0.13x $251.65 Million